Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Rheumatology

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/RHEUMATOLOGY/KEH297PMID 15238643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Nijmegen inception cohort of early rheumatoid arthritis.

  2004cited by this paper
• The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis.

  2004cited by this paper
• Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.

  2003cited by this paper
• Guidelines for the Management of Rheumatoid Arthritis

  2002cited by this paper
• Guidelines for the management of rheumatoid arthritis: 2002 Update.

  2002cited by this paper
• Clinical outcome measures in rheumatoid arthritis

  2000cited by this paper
• Clinical outcome measures in rheumatoid arthritis

  2000influential reference
• Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.

  1998cited by this paper
• Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.

  1998cited by this paper
• Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score.

  1996cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• A longitudinal analysis

  1992cited by this paper
• Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

  1990cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Remission in rheumatoid arthritis.

  1985cited by this paper
• Preliminary criteria for clinical remission in rheumatoid arthritis.

  1981influential reference

• Peripheral ulcerative keratitis (PUK) in autoimmune diseases: a severe ocular manifestation not always associated with systemic disease activity.

  2026cites this paper
• The impact of anti-TNF-α therapy on leptin and inflammatory markers in rheumatoid arthritis patients: a case-control study

  2025cites this paper
• Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: final analysis of an all-case post-marketing surveillance study.

  2025cites this paper
• Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)

  2025influential citation
• Relapse Rate After Glucocorticoid-free Remission in patients with Idiopathic Inflammatory Myopathies and Validation of the International Myositis Assessment and Clinical Studies Group (IMACS) Criteria for Complete Clinical Response and Worsening.

  2025cites this paper
• Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR

  2025cites this paper
• HLA-DRB1 allele distribution in Chilean population: insights into rheumatoid arthritis susceptibility and protection

  2025cites this paper
• Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy

  2024influential citation
• Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial

  2024cites this paper
• Exploring the Effect of Sampling Frequency on Real-World Mobility, Sedentary Behaviour, Physical Activity and Sleep Outcomes Measured with Wearable Devices in Rheumatoid Arthritis: Feasibility, Usability and Practical Considerations

  2024cites this paper
• What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit

  2024cites this paper
• Obesity in rheumatoid arthritis: impact on response to biologic therapies

  2024cites this paper
• Association of patient- and hospital-level predictors with patterns of initial treatment in patients with rheumatoid arthritis: findings from a national cohort study

  2024cites this paper
• Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort

  2024cites this paper
• Impact of MTHFR gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients

  2024cites this paper
• Impact of TYMS gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients – identification of novel single nucleotide polymorphism: Cross-sectional study

  2024cites this paper
• Evaluation of the role of hydroxychloroquine as a lipid profile improving and glucose adjusting drug in Egyptian females with inactive rheumatoid arthritis

  2023cites this paper
• Oral Microbial Signature of Rheumatoid Arthritis in Female Patients

  2023cites this paper
• The Effects and Potential Mechanisms of Moxibustion for Rheumatoid Arthritis-Related Pain: A Randomized, Controlled Trial

  2023cites this paper
• Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study

  2023cites this paper
• Prevalence of remission in patients with rheumatoid arthritis in daily clinical practice: long-term data from a tertiary care centre.

  2023cites this paper
• Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 patients with RA: a matched-analysis of the BSRBR-RA

  2023influential citation
• Physical Activity Influences Health-Related Quality of Life in Adults with Juvenile Idiopathic Arthritis

  2023cites this paper
• Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis

  2023cites this paper
• Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial

  2023cites this paper
• Correlation Between Rheumatoid Arthritis Activity with Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio: A Case-Control Study

  2023cites this paper
• Moxibustion as an adjunctive treatment for rheumatoid arthritis and its effects on the serum levels of SOST and β-catenin.

  2023cites this paper
• Prediction of flare following glucocorticoids withdrawal in rheumatoid arthritis patients with continuation of csDMARDs: a real-life study

  2023cites this paper
• Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA

  2023influential citation
• Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.

  2023cites this paper
• Efficacy of montelukast as an adjuvant therapy in rheumatoid arthritis patients: A randomized controlled study.

  2023cites this paper
• Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

  2023cites this paper
• Does Pizza Consumption Favor an Improved Disease Activity in Rheumatoid Arthritis?

  2023cites this paper
• Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience

  2023influential citation
• Evaluation of serum Interleukin 36 in Iraqi patients with Rheumatoid arthritis

  2023cites this paper
• A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures

  2023influential citation
• Safety and effectiveness of intravenous CT-P13 in inflammatory arthritis: post-marketing surveillance study in Thailand.

  2023cites this paper
• COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort

  2023cites this paper
• Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial

  2023cites this paper
• Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis

  2022cites this paper
• The Clinical Impact of Seropositivity on Treatment Response in Patients with Rheumatoid Arthritis Treated with Etanercept: A Real-World Iraqi Experience

  2022cites this paper
• Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics – A Single Centre Experience

  2022cites this paper
• OARRR_A_368190 113..121

  2022cites this paper
• Inter‐alpha‐trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis

  2022cites this paper
• IL-34 and protein-tyrosine phosphatase receptor type-zeta-dependent mechanisms limit arthritis in mice

  2022cites this paper
• Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels

  2022cites this paper
• Comparison of Efficacy of Acupuncture-Related Therapy in the Treatment of Rheumatoid Arthritis: A Network Meta-Analysis of Randomized Controlled Trials

  2022cites this paper
• Assessment of inflammation in patients with rheumatoid arthritis using thermography and machine learning: a fast and automated technique

  2022cites this paper
• Association of serum hepatoma‐derived growth factor levels with disease activity in rheumatoid arthritis: A pilot study

  2022cites this paper
• Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept

  2022cites this paper
• Pharmacokinetics and bioequivalence evaluation of 2 oral formulations of methotrexate tablets in healthy Chinese volunteers under fasting and fed conditions

  2022cites this paper
• Analysis of Association between Interleukin-6 (<i>IL</i>6), Interleukin-13 (<i>IL</i>13) and Tumor Necrosis Factor-Alpha (<i>TNF-alpha</i>) Gene Polymorphisms and Genetic Susceptibility of Rheumatoid Arthritis in Kuwaiti Arab

  2022cites this paper
• Implication and utility of DAS-28 squeeze in rheumatoid arthritis: an Indian experience.

  2022cites this paper
• Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study

  2022cites this paper
• Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort

  2022cites this paper
• Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study

  2022cites this paper
• The effect of a tight control regime with monthly follow-up on remission rates and reported pain in early rheumatoid arthritis.

  2022cites this paper
• A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial

  2022cites this paper
• Clinical Advantage of Attaining Index-Based Remission Prior to Composite Remission in Treating Rheumatoid Arthritis.

  2021cites this paper
• Erythrocyte reduced/oxidized glutathione and serum thiol/disulfide homeostasis in patients with Rheumatoid Arthritis.

  2021cites this paper
• Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020

  2021cites this paper
• Foot and Ankle Problems in Patients With Rheumatoid Arthritis in 2019: Still an Important Issue

  2021cites this paper
• Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.

  2021cites this paper
• Disease activity and its predictors in early inflammatory arthritis: findings from a national cohort

  2021cites this paper
• Lipid, fatty acid, carnitine- and choline derivative profiles in rheumatoid arthritis outpatients with different degrees of periodontal inflammation

  2021cites this paper
• Synergistic effect of sarcopenia and poor balance on osteoporotic vertebral fracture in Chinese patients with rheumatoid arthritis

  2021cites this paper
• Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis

  2021cites this paper
• Heterogenous bone response to biologic DMARD therapies in rheumatoid arthritis patients and their relationship to functional indices

  2021cites this paper
• Saturated fatty acids intake is associated with muscle atrophy in rheumatoid arthritis

  2021cites this paper
• Feasibility of Discontinuing Biologics in Severe Asthma: An Algorithmic Approach

  2021cites this paper
• Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis

  2021cites this paper
• The significance of serum 14-3-3η level in rheumatoid arthritis patients

  2021cites this paper
• Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases

  2021cites this paper
• Clinical Efficacy of Methotrexate Combined with Iguratimod on Patients with Rheumatoid Arthritis and Its Influence on the Expression Levels of HOTAIR in Serum

  2021cites this paper
• Temporomandibular disorders in patients with early rheumatoid arthritis and at-risk individuals in the Dutch population: a cross-sectional study

  2021cites this paper
• Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

  2021cites this paper
• Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well‐Being and Disease Activity

  2021cites this paper
• Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme

  2021cites this paper
• The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid Arthritis

  2021cites this paper
• Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

  2021cites this paper
• The Protein Tyrosine Phosphatase Non-receptor Type N22 (PTPN22) Gene Functional Polymorphism (1858T) is not Associated with Rheumatoid Arthritis in Kuwaiti Patients

  2021cites this paper
• Continuous effectiveness and safety after a hospital‐wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patients

  2021cites this paper
• Vitamin D Receptor FokI Gene Polymorphism in Rheumatoid Arthritis Patients

  2021cites this paper
• Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still’s Disease and Active Articular Manifestation Responding to Canakinumab

  2021cites this paper
• Infliximab switching from reference product to biosimilar: a review of evidence regarding the clinical efficacy, safety profile and immunogenicity

  2021cites this paper
• Current and future status of JAK inhibitors.

  2021cites this paper
• A Pragmatic Application of Ultrasonography for the Assessment of Disease Activity in Patients with Early Inflammatory Arthritis

  2021cites this paper
• NLRP3 gene polymorphisms and expression in rheumatoid arthritis

  2021cites this paper
• Rheumatoid Arthritis Diagnosis: Deep Learning vs. Humane

  2021cites this paper
• A Prospective, Randomized, Single-Center, Two-Arm, Open-Label Study to Evaluate the Efficacy of Biotherapi, a Two-Strain Bacillus Probiotic Blend, as an Adjunctive Therapy in the Treatment of Rheumatoid Arthritis

  2021influential citation
• Response to abatacept is associated with the inhibition of proteasome β1i expression in T cells of patients with rheumatoid arthritis

  2020cites this paper
• Effect of Moxibustion on the Serum Levels of MMP-1, MMP-3, and VEGF in Patients with Rheumatoid Arthritis

  2020cites this paper
• Effect ofMoxibustion on the SerumLevels ofMMP-1,MMP-3, and VEGF in Patients with Rheumatoid Arthritis

  2020cites this paper
• A nomogram to predict recurrence of RA patients in clinical remission within one year.

  2020cites this paper
• A double-blind placebo-controlled randomized trial of oral saffron in the treatment of rheumatoid arthritis

  2020cites this paper
• Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort

  2020cites this paper
• The evaluation of rheumatoid arthritis patients with knee and hip prosthesis: HURBIO biological registry

  2020cites this paper
• Unacceptable pain in the BARFOT inception cohort of patients with rheumatoid arthritis: a long-term study

  2020cites this paper
• Serum Level of ADAMTS4 and ADAMTS8 in Patients with Psoriatic Arthritis

  2020cites this paper
• A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis

  2020cites this paper